Adial Pharmaceuticals Submits Continuation Patent Application for Use of AD04 in Opioid Dependence and Abuse Feb 15, 2019
Adial Pharmaceuticals Appoints Leading Addiction Specialist to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder Feb 12, 2019
Dr. Bankole A. Johnson, Chairman of Adial Pharmaceuticals, Receives Prestigious American Society of Addiction Medicine Award Feb 7, 2019
Adial Pharmaceuticals CEO to Appear on CBS and Fox Affiliates to Discuss AD04 as a Potential Treatment for Alcohol and Opioid Use Disorder Feb 1, 2019
Adial Pharmaceuticals Receives $1.2 Million in Proceeds Through the Exercise of Warrants Jan 24, 2019
Adial Pharmaceuticals Appoints Two Additional Global Thought Leaders to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder Jan 17, 2019
Bankole Johnson, MD and Chairman of the Board of Adial Pharmaceuticals Featured in Second Installment of The Doctors Channel Video Series Jan 15, 2019
Adial Pharmaceuticals Announces Amendment to License Agreement with the University of Virginia Licensing & Ventures Group Dec 19, 2018
